Cumulative Analysis of Post-authorization Adverse Event Reports
fasciitis:
Eosinophilic granulomatosis with polyangitis,
Eosinophilic oesophagitis:
Epidermolysis:
Epilcpsy:
Epilepsy surgery:
Epilepsy with myoclonic-atonic scizures;
Epileptic aura;
Epileptic psychosis:
Erythema;
Erythema induratum;
Erythema multiforme:
Erythema nodosum,
Evans syndrome:
Exathema subitum,
Expanded disability status scale score decreased:
Expanded disability status scale score increased:
Exposure to communicable disease:
Exposure to SARS-CoV-2:
Eye oedema:
Eye pruritus:
Eye swelling:
Eyelid oedema:
Face ocdema;
Facial paralysis:
Facial paresis:
Faciobrachial dystonic seizure:
Fat embolism;
Febrile convulsion:
Febrile infection-related epilepsy syndrome;
Febrile neutropenia;
Felty's syndrome:
Femoral artery embolism:
Fibrillary glomerulonephritis,
Fibromyalgia:
Flushing :
Foaming at mouth:
Focal cortical resection:
Focal dyscognitive seizures:
Foetal distress syndrome:
Foetal placental thrombosis;
Foetor hepaticus:
Foreign body embolism:
Frontal lobe epilepsy:
Fulminant type 1 diabetes mellitus:
Galactose elimination capacity test abnormal:
Galactose elimination capacity test decreased;
Gamma-glutamyltransferase abnomal;
Gamma-glutamyltransferase increased:
Gastritis herpes;
Gastrointestinal amyloidosis;
Gelastic seizure:
Generalised onset non-motor seizure;
Generalised tonic-clonic seizure:
Genital herpes;
Genital herpes simplex;
Genital herpes zoster,
Giant cell arteritis;
Glomerulonephritis;
Glomerulonephritis membranoproliferative;
Glomerulonephritis membranous;:
Glomerulonephritis rapidly progressive:
Glossopharyngeal nerve paralysis
Glucose transporter type 1 deficiency syndrome;
Glutamate dehydrogenase increased;
Glycocholic acid increased:
GM2 gangliosidosi
Goodpasture's syndrome;
Graft thrombosis;
Granulocytopenia;
Granulocytopenia nconatal:
Granulomatosis with polyangitis:
Granulomatous dermatitis:
Barre syndrome:
Haemolytic anacmia;
Haemophagocytic lymphohistiocytosis:
Haemonhage:
Hae morhagic ascites:Hacmorhagic disorder:Haemorhagic pneumonia:Haemorhagic varicella syndrome:
Haemorhagic vasculitis; Hantavirus pulmonary infection:Hashimoto's encephalopathy:
Hashitoxicosis.
Hemimegalencephaly.
Henoch-Schonlein purpura;
Henoch- Schonlein purpura nephritis:
Hepaplastin abnomal:
Hepaplastin decreascd:
Heparin-induced thrombocytopenia:
Hepatic amyloidosis:
Hepatic artery embolism,
Hepatic artery flow deereased:
Hepatic artery thrombosis:
Hepatic enzyme abnormal:
Hepatic enzyme decreased;
Hepatic enzyme increased
Hepatic fibrosis marker abnormal:
Hepatic fibrosis marker increased:
Hepatic function abnormal:
Hepatic hydrothorax:
Hepatic hypertrophy:
Hepatic hypoperfusion:
Hepatic lymphocytic infiltration:
Hepatic mass:Hepatic pain:
Hepatic scquestration:
Hepatic vascular resistance increased:
Hepatic vascular thrombosis:
Hepatic vein embolism;
Hepatic vein thrombosis:
Hepatic venous pressure gradient abnormal:
Hepatic venous pressure gradient increased;
Hepatitis:
Hepatobiliary scan abnormal:
Hepatome galy:
Hepatosplenomegaly,
Hereditary angioedema with Cl esterase inhibitor deficiency:
Herpes dermatitis:
Herpes gestationis:
Herpes oesophagitis:
Herpes ophthalmic:
Herpes pharyngitis:
Herpes sepsis:
Herpes simplex:
Herpes simplex cervicitis:
Herpes simplex colitis:
Herpes simplex encephalitis:
Herpes simplex gastritis:
Hepes simplex hepatitis:
Herpes simplex meningitis:
Herpes simplex meningoencephalitis
Herpes simplex meningomyelitis:
Herpes simplex necrotising retinopathy:
Herpes simplex oesophagitis:
Herpes simplex otitis externa:Herpes simplex pharyngitis:
Herpes simplex pneumonia :
Herpes simplex reactivation:
Herpes simplex sepsis:
Herpes simplex viraemia:
Herpes simplex vinus conjunctivitis neonatal;:
Herpes simplex visceral;
Herpes vinus matter heterotopia:
Guanase increased;
Guillain-
CONFIDENTIAL
Page 4
FDA-CBER-2021-5683-0000086 Pag
No comments:
Post a Comment